Zenotech Laboratories

60.30
+0.68
(1.14%)
ann
There are new updates from the company1 day ago
Viewcross
right
Market Cap
368.05 Cr
EPS
1.36
PE Ratio
93.16
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
107.79
52 Week Low
51.00
PB Ratio
3.91
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,747.40
#1 4,19,259.79
35.48
#1 49,887.20
12.06
#1 9,648
13.77
55.47
5,911.50
1,56,931.75
75.63
8,184.00
0.89
1,600
#1 64.53
57.94
1,528.20
1,23,419.72
24.47
26,520.70
14.17
4,155
47.38
59.76
3,246.40
1,09,872.93
59.14
10,785.70
11.59
1,656
13.54
55.97
2,579.50
1,06,424.63
52.21
10,615.60
19.57
1,942
-16.38
64.88
1,175.00
98,048.51
#1 18.29
28,905.40
12.36
5,578
1.69
56.24
2,046.70
93,440.24
31.97
20,141.50
#1 19.94
1,936
38.82
53.70
852.70
85,801.57
18.76
19,831.50
13.82
3,831
29.92
44.48
1,187.70
68,981.81
19.78
29,559.20
17.55
3,169
-10.04
57.69
31,015.00
65,904.71
49.20
6,097.20
10.80
1,201
16.01
58.75
Growth Rate
Revenue Growth
-3.91 %
Net Income Growth
-28.45 %
Cash Flow Change
-42.79 %
ROE
-34.87 %
ROCE
-30.68 %
EBITDA Margin (Avg.)
-13.00 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
4
2
2
14
18
27
23
37
44
42
43
Expenses
24
10
13
19
17
17
16
19
22
24
28
EBITDA
-20
-8
-10
-6
1
10
7
18
22
18
16
Operating Profit %
-492 %
-373 %
-462 %
-71 %
-27 %
35 %
28 %
48 %
49 %
42 %
23 %
Depreciation
4
4
4
4
4
5
7
7
7
7
7
Interest
7
8
8
2
0
1
2
1
0
0
0
Profit Before Tax
-30
-19
-20
-12
-3
11
-1
10
15
11
9
Tax
0
0
0
0
0
0
0
-12
3
3
0
Net Profit
-30
-19
-20
-12
-3
11
-1
22
12
8
5
EPS in ₹
-8.83
-5.56
-5.77
-2.24
-0.51
1.77
-0.20
3.63
1.90
1.36
0.80

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
64
53
51
82
85
86
86
94
101
106
Fixed Assets
52
48
47
44
43
49
74
71
65
66
Current Assets
9
3
2
31
19
6
7
7
16
26
Capital Work in Progress
0
0
0
2
17
29
2
0
5
2
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
12
5
4
35
25
8
9
23
31
39
Total Liabilities
64
53
51
82
85
86
86
94
101
106
Current Liabilities
91
99
116
39
45
35
15
16
17
14
Non Current Liabilities
0
0
0
0
0
1
23
8
2
2
Total Equity
-27
-46
-66
42
39
50
48
71
82
91
Reserve & Surplus
-62
-81
-100
-19
-22
-11
-13
10
21
30
Share Capital
34
34
34
61
61
61
61
61
61
61

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
-0
0
28
-15
-12
1
0
9
-9
Investing Activities
0
6
-1
-3
-16
-21
-5
-2
-6
-21
Operating Activities
-8
-5
2
-16
-14
11
6
18
21
12
Financing Activities
7
-1
-1
47
15
-3
0
-16
-6
0

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
68.84 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.01 %
0.01 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
0.98 %
Public / Retail
26.40 %
26.41 %
26.42 %
22.36 %
22.47 %
22.50 %
22.84 %
22.65 %
22.67 %
22.57 %
22.50 %
22.59 %
22.65 %
22.72 %
22.66 %
22.83 %
22.78 %
Others
4.75 %
4.74 %
4.73 %
8.79 %
8.68 %
8.65 %
7.34 %
7.52 %
7.50 %
7.60 %
7.67 %
7.58 %
7.52 %
7.45 %
7.51 %
7.34 %
7.39 %
No of Share Holders
6,537
6,764
7,299
7,566
7,760
8,014
7,930
8,746
9,142
9,249
9,589
9,762
9,819
9,750
10,641
10,667
10,690

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Board Meeting Intimation for Considering And Approving Audited Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2025.1 day ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20187 days ago
Announcement under Regulation 30 (LODR)-Change in DirectorateMar 30, 2025
Closure of Trading WindowMar 26, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 15, 2025
Integrated Filing (Financial)Feb 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 30, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On January 28 2025Jan 28, 2025
Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 28, 2025
Board Meeting Intimation for Approval Of Financial Results For The Quarter And Nine Months Ended December 31 2024.Jan 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Closure of Trading WindowDec 27, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 07, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 24, 2024
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024 And Appointment Of Dr. Sachin Laxmanappa Gavandare As Chief Executive Officer (Key Managerial Personnel) Of The Company With Immediate Effect.Oct 23, 2024
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 23, 2024
Board Meeting Intimation for Consideration And Approval Of Financial ResultsOct 17, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 15, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 28, 2024
Closure of Trading WindowSep 27, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 27, 2024
Clarification On Price MovementSep 12, 2024
Clarification sought from Zenotech Laboratories LtdSep 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024
Notice Of 35Th Annual General Meeting Of Zenotech Laboratories Limited To Be Held On Friday, September 27, 2024 At 10:30 A.M. IST Through VCSep 02, 2024
Reg. 34 (1) Annual Report.Sep 02, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 24, 2024
Intimation Of 35Th Annual General Meeting Of Zenotech Laboratories Limited (The Company)Aug 23, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2024
Outcome Of The Board Meeting Held Today, I.E., July 26, 2024 - Unaudited Standalone Financial Results For The Quarter Ended June 30, 2024Jul 26, 2024
Unaudited Standalone Financial Results For The Quarter Ended June 30, 2024Jul 26, 2024
Relieving Of Chief Executive Officer (Key Managerial Personnel) Of Zenotech Laboratories LimitedJul 25, 2024
Board Meeting Intimation for Approval Of Quarterly Standalone Financial Results For Q1 Of FY 2024-25Jul 18, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jul 09, 2024
Closure of Trading WindowJun 26, 2024
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 21, 2024
Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)May 17, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 03, 2024
Board Meeting Outcome for Submission Of Audited Standalone Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2024May 01, 2024
Audited Standalone Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2024May 01, 2024
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 29, 2024
Board Meeting Intimation for Consideration And Approval Of Audited Standalone Financial Results Of The Company For The Fourth Quarter And Financial Year Ended March 31, 2024Apr 24, 2024
Compliance Certificate Under Regulation 40(9) & (10) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Apr 24, 2024
Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended March 31, 2024Apr 06, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Apr 06, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMApr 06, 2024
Closure of Trading WindowMar 27, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2024

Technical Indicators

RSI(14)
Neutral
54.21
ATR(14)
Less Volatile
3.63
STOCH(9,6)
Neutral
59.27
STOCH RSI(14)
Neutral
59.12
MACD(12,26)
Bullish
0.33
ADX(14)
Weak Trend
23.84
UO(9)
Bearish
36.39
ROC(12)
Uptrend And Accelerating
14.83
WillR(14)
Neutral
-36.69